Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Coagulation

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Red Cell Damage During Extracorporeal Life Support.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2024

Same author

Causes of red blood cell loss during extracorporeal membrane oxygenation.

Transfusion·2023

Same author

Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients.

American journal of clinical pathology·2022

Same author

Causes of platelet loss during extracorporeal life support.

Artificial organs·2022

Same author

Coagulation activation during extracorporeal membrane oxygenation (ECMO).

Thrombosis research·2022

Same author

Thrombosis in Extracorporeal Membrane Oxygenation (ECMO) Circuits.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2021

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Procoagulant activity in trauma patients.

Wayne L Chandler¹

¹Dept of Laboratory Medicine, University of Washington, Seattle, 98195, USA.

American Journal of Clinical Pathology

|June 17, 2010

Summary

Trauma patients show higher procoagulant activity. Those with coagulopathy have significantly increased circulating tissue factor, a key procoagulant, indicating its role in trauma-induced coagulation disorders.

Area of Science:

Hematology
Trauma Medicine
Coagulation Science

Background:

Elevated circulating procoagulants, such as tissue factor, are linked to systemic coagulation activation and consumptive coagulopathy.
Trauma can disrupt normal hemostasis, leading to potentially life-threatening bleeding or clotting complications.

Purpose of the Study:

To quantify procoagulant activity and tissue factor-specific activity in trauma patients.
To investigate the association between circulating tissue factor levels and coagulopathy development in trauma patients.

Main Methods:

A clot-based assay was employed to measure plasma procoagulant activity.
The assay incorporated specific reagents to isolate and quantify tissue factor activity, including anti-tissue factor antibodies.
Procoagulant and tissue factor activity were assessed in 58 trauma patients and control subjects.

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Main Results:

Trauma patients without coagulopathy exhibited 5-fold higher procoagulant activity than controls.
Trauma patients with coagulopathy showed 10-fold higher procoagulant activity than controls and 2-fold higher than trauma patients without coagulopathy.
Tissue factor activity was significantly elevated (3- to 4-fold) in trauma patients with coagulopathy compared to those without.

Conclusions:

Trauma patients, particularly those with coagulopathy, have significantly increased circulating tissue factor activity.
Elevated tissue factor is a key contributor to the procoagulant state observed in trauma-induced coagulopathy.